Work

Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ42 oligomers via a metalloproteinase-dependent mechanism

Year: 2013

Type: article

Source: Brain Research

DOI: 10.1016/j.brainres.2013.05.006

Authors: Karin E. Sandoval, Susan A. Farr, William A. Banks, Albert M. Crider, John E. Morley, Ken A. Witt

Institutions: Southern Illinois University Edwardsville, Veterans Health Administration, St. Louis VA Medical Center, John Cochran VA Medical Center, Saint Louis University, University of Washington, VA Puget Sound Health Care System

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, University of Illinois at Urbana-Champaign, National Institute on Aging

Award: Somatostatin Agonist Treatment for Cognitive Aging and Dementia

OpenAlex ID: W2032699086

FWCI: 0.695

Cites: 54

Cited by: 30

Related to: 10